Clinical Trials Logo

Nausea clinical trials

View clinical trials related to Nausea.

Filter by:

NCT ID: NCT03641625 Completed - Clinical trials for Postoperative Nausea and Vomiting

Effect of SmtO2 Guided Care on PONV (iMODIPONV)

iMODIPONV
Start date: September 15, 2018
Phase: N/A
Study type: Interventional

This randomized controlled trial is to investigate if SmtO2-guided management on top of the usual care, compared with the usual care only, during laparoscopic hysterectomy significantly reduces the incidence of PONV.

NCT ID: NCT03631004 Completed - Clinical trials for Postoperative Nausea and Vomiting

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Start date: October 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

Olanzapine has been used as prophylactic antiemetic for chemotherapy induced nausea and vomiting. The project aims to evaluate the efficacy of olanzapine in combination with ondansetron and dexamethasone in patients at high risk of postoperative nausea and vomiting, with previous history of nausea and vomiting induced by prior chemotherapy, submitted to medium and large surgery.

NCT ID: NCT03627780 Completed - Clinical trials for Genetic Predisposition to Disease

Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV)

ponv
Start date: January 2, 2017
Phase:
Study type: Observational

Nausea and vomiting affects 25-30% of individuals in the post-operative period and can reach more than 70-80% in high-risk patients. inherited factors may play a significant role in individual susceptibility and clinical research on hereditary factors involved in the pathogenesis of Postoperative nausea and vomiting (PONV) and chemotherapy nausea and vomiting (CINV) is relatively new. The aim of this study is to investigate whether inter-individual differences related to PONV are associated with genetic factors. 300 patients will be evaluated in postoperative oncological surgeries. The peripheral leukocyte DNA will be extracted by the Salting Out Procedure method and processed to genotyping for 48 SNPs from 15 candidate genes by real-time PCR by the Taqman method. The possible associations with demographic data and factors related to surgery will be analyzed by univariate and multivariate analysis.

NCT ID: NCT03626441 Completed - Clinical trials for Postoperative Nausea and Vomiting

The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting

Start date: December 2, 2017
Phase: Phase 2
Study type: Interventional

This study evaluates the effectiveness of ginger on the incidence of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Half the patients were given an oral dose of ginger preoperatively and half received placebo.

NCT ID: NCT03621722 Completed - Anxiety Clinical Trials

AroMatherapy for Blood and Marrow Transplant PatIENTs (AMBIENT)

AMBIENT
Start date: February 27, 2017
Phase: N/A
Study type: Interventional

The study is comparing the difference between the use of Elequil Aromatabs versus standard of care practice treatments on Blood Marrow Transplantation patients.

NCT ID: NCT03603119 Completed - Clinical trials for Postoperative Nausea and Vomiting

Midazolam Versus Dexamethasone-ondansetron in Preventing Postoperative Nausea-vomiting for Laparoscopic Surgeries

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Postoperative nausea and vomiting(PONV) affects 11 to 60 % of patients undergoing surgery and is a major cause of postoperative morbidity. Risk factors include female gender, non smokers, postoperative use of opioids and a past history of PONV. The simplified Apfel risk score is used to identify patients at risk for PONV. PONV prophylaxis is provided intraoperatively to patients with 2 or more risk factors. In spite of numerous drugs available, control of PONV remains a difficult task. Midazolam is a commonly used drug perioperatively for its anxiolytic and sedative properties. It decreases analgesic requirement and has also been found to have an antiemetic effect. This present study is designed to compare the prophylactic use of iv midazolam with a commonly used combination of dexamethasone-ondansetron in high risk patients (as defined by the modified Apfel score) undergoing laparoscopic surgeries.

NCT ID: NCT03601871 Recruiting - Clinical trials for Chemotherapy-induced Nausea and Vomiting

The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy

Start date: July 12, 2018
Phase: N/A
Study type: Interventional

This is a pragmatic randomized, multi-center, open-label randomized clinical trial, aimed to evaluate efficacy and safety of thalidomide in improving prevention of chemotherapy-induced delayed nausea and vomiting (CINV) in chemotherapy-naive patients after multi-cycle cisplatin-containing highly emetogenic chemotherapy (HEC) .

NCT ID: NCT03599427 Completed - Surgery Clinical Trials

Added Value of Systemic Lidocaine on Postoperative Pain, Opiate Use and Nausea After Knee Arthroscopy

Start date: September 1, 2018
Phase: Phase 4
Study type: Interventional

Local intra-articular injection of anesthetics (LIA) is increasingly used during knee arthroscopy for pain relief. The LIA can only be performed at the end of surgery as the knee joint is continuously flushed during the arthroscopy. As a consequence, an optimal analgesic effect is only obtained one hour after surgery and opiates are typically used as pain relief in the immediate postoperative period. Since these opiates have a number of side effects such as nausea, vomiting and drowsiness, other analgetic methods are desirable. Intravenous administration of lidocaine, a safe, inexpensive analgesic, is already used in major (abdominal) surgeries and might also be a promising method for pain relief in the first hour after knee arthroscopy, in anticipation of the onset of the analgesic effect of the LIA. The aim of this study is to verify if systemic administration of lidocaine has a beneficial effect on the pain immediately after knee arthroscopy. In addition, the effect of systemic lidocaine administration on postoperative nausea, vomiting and general patient comfort will be evaluated.

NCT ID: NCT03593811 Enrolling by invitation - Nausea Clinical Trials

Noninvasive Markers of Functional Nausea in Children

Start date: August 3, 2018
Phase: N/A
Study type: Interventional

The researchers propose to study how functional nausea in adolescents may be characterized noninvasively by the use of multichannel electrogastrogram (EGG) and magnetogastrogram (MGG) recordings.

NCT ID: NCT03588338 Completed - Clinical trials for Postoperative Nausea and Vomiting

Paracetamol on Postoperative Nausea and Vomiting

Start date: July 20, 2018
Phase: Phase 4
Study type: Interventional

The drugs with both high potency and low side effects are preferred in the prevention of postoperative nausea and vomiting (PONV) which is a common problem. This prospective randomized study aimed to compare the efficacy of paracetamol on PONV in adults undergoing maxillofacial surgery.